| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 02/22/2012 | CN102357112A Method for preparing total saponins from wild honeysuckle flower |
| 02/22/2012 | CN102357104A Use of a combination of myxoma virus and rapamycin for therapeutic treatment |
| 02/22/2012 | CN102357101A Application of dendritic cell combined with cytokine-induced killer cell in lung cancer treatment |
| 02/22/2012 | CN102357100A Anti-tumor combination medicament |
| 02/22/2012 | CN102357080A Intelligent multifunctional hollow microsphere capable of quickly releasing medicine in acid environment and preparation method for intelligent multifunctional hollow microsphere |
| 02/22/2012 | CN102357079A Carboxymethyl chitosan nanoparticles modified with glycyrrhizic acid, preparation method and application thereof |
| 02/22/2012 | CN102357075A Docetaxel nano preparation and preparation method thereof |
| 02/22/2012 | CN102357074A Anti-tumor multi-medicine resistant targeted liposome |
| 02/22/2012 | CN102357072A Injection preparation of T-2 lienomycin |
| 02/22/2012 | CN102357071A Taxol-carried nano microbubble and preparation method thereof |
| 02/22/2012 | CN102078409B Traditional Chinese medicine preparation for treating liver cancer |
| 02/22/2012 | CN102068415B 一种咔唑磺酰胺类抗肿瘤药物分散片及其制备方法 One kind of carbazole sulfonamides antineoplastic tablet and its preparation method |
| 02/22/2012 | CN101985432B 3-Fmoc胺基-3-（3-硝基-4-氟苯基）丙酸及其制备方法 3-Fmoc-3- (3-nitro-4-fluorophenyl) propionic acid and its preparation method |
| 02/22/2012 | CN101875922B 一种重组苛求芽孢杆菌胞内尿酸酶及其聚乙二醇修饰与应用 A recombinant Bacillus cells within demanding its PEGylated uricase and Applications |
| 02/22/2012 | CN101805385B 从羽芒菊中分离纯化的黄酮类化合物及其制备方法 Flavonoids isolated from purified Ju Yu Mang and its preparation method |
| 02/22/2012 | CN101805285B 含烟酸姜黄素酯衍生物及其制造方法和用途 Nicotinic acid ester derivatives containing curcumin and its manufacturing method and use thereof |
| 02/22/2012 | CN101785757B 一种紫杉醇自乳化制剂及其制备方法和用途 One of paclitaxel self-emulsifying formulation and preparation method and uses |
| 02/22/2012 | CN101747451B 一种靶向粘附壳聚糖材料及其应用 Which targets the adhesion of chitosan materials and their applications |
| 02/22/2012 | CN101745065B 一种具有抗癌止痛作用的药物组合物 A pharmaceutical composition having an anticancer analgesic effect |
| 02/22/2012 | CN101721435B 一种灵芝孢子粉纳米硒复合物及其制备方法 One kind of fungus spores on nano selenium compound and preparation method |
| 02/22/2012 | CN101716318B 一种用于辅助化疗方式治疗消化系统肿瘤的中药制剂 An adjuvant chemotherapy Chinese medicine for the treatment of digestive tumors way |
| 02/22/2012 | CN101607942B 一类抗肿瘤化合物及其制备方法 A class of anti-cancer compounds and methods |
| 02/22/2012 | CN101584718B 对萼猕猴桃叶提取物及其制备方法和用途 Calyx kiwi leaf extract for its preparation and use |
| 02/22/2012 | CN101579424B 一种治疗癌症的中草药制剂 Chinese herbal medicine for treating cancer |
| 02/22/2012 | CN101428071B 一种白头翁的有效组分及其制备方法与用途 Effective ingredients and preparation methods and the use of a bulbul |
| 02/22/2012 | CN101407557B 一种金钗石斛多糖提取物的制备和应用 A preparation and application of Dendrobium nobile polysaccharide extract |
| 02/22/2012 | CN101353656B 抑制表皮生长因子受体基因表达的siRNA及其应用 Inhibition of epidermal growth factor receptor gene expression and its application siRNA |
| 02/22/2012 | CN101153054B 用于血管生成治疗的小肽及其应用 Angiogenic therapy for small peptide and its application |
| 02/22/2012 | CN101088492B 盐酸吉西他滨稳定的过饱和溶液及其制备方法 Gemcitabine hydrochloride stable supersaturated solution and its preparation method |
| 02/22/2012 | CN101015525B 紫杉醇脂质体及其制备方法 Paclitaxel liposome preparation method thereof |
| 02/21/2012 | US8119819 Malonyl-CoA decarboxylase inhibitors useful as metabolic modulators |
| 02/21/2012 | US8119774 Cell marker for hepatic and pancreatic stem cells and progenitor cells |
| 02/21/2012 | US8119691 Method for treating airway hyper-responsiveness with lipoxin analogs |
| 02/21/2012 | US8119687 Derivatives of dioxan-2-alkyl carbamates, preparation thereof and application thereof in therapeutics |
| 02/21/2012 | US8119678 Compounds, compositions and methods |
| 02/21/2012 | US8119649 Use of c-Src inhibitors alone or in combination with STI571 for the treatment of leukaemia |
| 02/21/2012 | US8119638 Compositions and uses of ET743 for treating cancer |
| 02/21/2012 | US8119631 Inhibitors of interleukin-1β converting enzyme |
| 02/21/2012 | US8119614 Substitution derivatives of N6-benzyladenosine, methods of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosmetic preparations and growth regulators containing these compounds |
| 02/21/2012 | US8119608 Specific inhibition of expression of target gene in mammals using short double stranded RNA; dsRNA less than 49 nucleotides in length, has nucleotide sequence complementary to part of target gene; treating cancer, Alzheimer's disease |
| 02/21/2012 | US8119604 Polypeptide formulation |
| 02/21/2012 | US8119396 Recombinant adenoviral vectors and applications thereof |
| 02/21/2012 | US8119132 Humanized anti-tag-72 monoclonal antibodies |
| 02/21/2012 | US8119116 Therapeutics for cancer using 3-bromopyruvate and other selective inhibitors of ATP production |
| 02/21/2012 | CA2633077C Solid-state form of amg 706 and pharmaceutical compositions thereof |
| 02/21/2012 | CA2610794C Derivatives of pyrido[2,3-d]pyrimidine, the preparation thereof, and the therapeutic application of the same |
| 02/21/2012 | CA2568995C Construction of oncolytic adenovirus recombinant specifically expressing immune modulatory factor gm-csf in tumor cells and uses thereof |
| 02/21/2012 | CA2534585C Human anti-ngf neutralizing antibodies as selective ngf pathway inhibitors |
| 02/21/2012 | CA2529531C Stable 5,10-methylene-tetrahydrofolate pharmaceutical compounds |
| 02/21/2012 | CA2512797C Bis (thio-hydrazide amide) compounds for treating multi-drug resistant cancer |
| 02/21/2012 | CA2488372C Pyridazine derivatives which are phosphodiasterase iv inhibitors |
| 02/21/2012 | CA2478542C Aminoindazole derivatives, their method of preparation and intermediaries of this process as medicines and pharmaceutical compositions containing same |
| 02/21/2012 | CA2451981C 2,4,5-trisubstituted thiazolyl derivatives and their antiinflammatory activity |
| 02/21/2012 | CA2444031C 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 02/21/2012 | CA2418962C Anti-dual integrin antibodies, compositions, methods and uses |
| 02/21/2012 | CA2407680C Dendritic cell co-stimulator molecules |
| 02/21/2012 | CA2400141C Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and preparation thereof |
| 02/21/2012 | CA2394716C Hydrolytically degradable carbamate derivatives of poly(ethylene glycol) |
| 02/21/2012 | CA2373300C Compositions and methods for generating an immune response utilizing alphavirus-based vector systems |
| 02/21/2012 | CA2354045C New cancer treatments |
| 02/21/2012 | CA2349760C Bovine cells expressing adeno virus essential functions for propagation of recombinant adenoviral vectors |
| 02/21/2012 | CA2302866C Genetically modified tumor-targeted bacteria with reduced virulence |
| 02/21/2012 | CA2264592C Bioconjugates and delivery of bioactive agents |
| 02/17/2012 | CA2750329A1 Downregulation of spy1 by p53 as an essential component of p53-mediated effects |
| 02/16/2012 | WO2012021845A2 Improved hematopoietic stem and progenitor cell therapy |
| 02/16/2012 | WO2012021840A2 Materials and methods for designing autologous idiotype vaccines and treatment of b-cell malignancies |
| 02/16/2012 | WO2012021558A1 Methods and compositions for preventing a condition |
| 02/16/2012 | WO2012021512A2 Erythrocyte-binding therapeutics |
| 02/16/2012 | WO2012021486A2 Acylsulfonamides and processes for producing the same |
| 02/16/2012 | WO2012021249A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of histidyl-trna synthetases |
| 02/16/2012 | WO2012021247A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-trna synthetases |
| 02/16/2012 | WO2012021016A2 Lacobacillus strain having anti-cancer activity and anti-cancer activity composition including same as active ingredient |
| 02/16/2012 | WO2012020892A1 Rhus verniciflua stokes extract having increased content of active flavonoid compound and method for preparing same |
| 02/16/2012 | WO2012020871A1 Composition for preventing or treating cervical cancer having human papillomavirus plasmodium and immunity enhancer |
| 02/16/2012 | WO2012020842A1 Complex having tumor vaccine effect, and use thereof |
| 02/16/2012 | WO2012020839A1 Pharmaceutical composition for cancer therapy |
| 02/16/2012 | WO2012020787A1 Malignant lymphoma therapeutic agent |
| 02/16/2012 | WO2012020786A1 Pharmaceutical composition |
| 02/16/2012 | WO2012020785A1 Medicinal agent for prevention and/or treatment of hepatocellular carcinoma |
| 02/16/2012 | WO2012020767A1 Pyrroloquinoline quinone gel |
| 02/16/2012 | WO2012020762A1 Hetero ring compound |
| 02/16/2012 | WO2012020757A1 Production method for cell populations |
| 02/16/2012 | WO2012020726A1 Inhibitor of casein kinase 1δ and casein kinase 1ε |
| 02/16/2012 | WO2012020622A1 Fragment of humanized anti-egfr antibody substituted-lysine variable fragment and use thereof |
| 02/16/2012 | WO2012020566A1 Highly functionalized stem cell/progenitor cell by ape1 gene transfection |
| 02/16/2012 | WO2012020364A1 Di peptide derivative for the treatment of cancer |
| 02/16/2012 | WO2012020227A1 Tricyclic compounds for use as kinase inhibitors |
| 02/16/2012 | WO2012020217A1 Amino- imidazolothiadiazoles for use as protein or lipid kinase inhibitors |
| 02/16/2012 | WO2012020215A1 Amino- imidazolothiadiazoles for use as protein or lipid kinase inhibitors |
| 02/16/2012 | WO2012020162A1 Use of antibodies against nk1, nk2 and/or nk3 receptors in cancer treatment |
| 02/16/2012 | WO2012020059A1 Humanized egfr antibodies |
| 02/16/2012 | WO2012020021A1 Glycyrrhetinic acid amine analogues for use in the treatment of inflammation, infectious diseases, cancer, autoimmune diseases, skin diseases, bone diseases and metabolic diseases |
| 02/16/2012 | WO2012019633A1 Pharmaceutical granulate comprising imatinib mesylate |
| 02/16/2012 | WO2012019437A1 Bladder cancer tumor marker, antibiotic and application thereof |
| 02/16/2012 | WO2012019430A1 Phthalazinone derivative, and preparation method and pharmaceutical use thereof |
| 02/16/2012 | WO2012019427A1 Phthalazinone ketone derivative, preparation method thereof, and pharmaceutical use thereof |
| 02/16/2012 | WO2012019426A1 Phthalazinone derivative, and preparation method and pharmaceutical use thereof |
| 02/16/2012 | WO2012019423A1 Angiogenesis inhibitor, method for purifying thereof and pharmaceutical composition comprising thereof |
| 02/16/2012 | WO2012019284A1 Combinatory cancer treatment |
| 02/16/2012 | WO2011154846A3 4, 6 -dibenzoylamino- 2 -methyl- pyrimidine derivatives and their use for the treatment of cancer |